Lixue Yang

No.225, Changhai Rd
Shanghai, 200438, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Ferroptosis meets inflammation: A new frontier in cancer therapy.

Ferroptosis meets inflammation: A new frontier in cancer therapy.

Journal: Cancer letters

Published: February 02, 2025

Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma.

Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma.

Journal: Genomics

Published: May 01, 2024

Anoikis-related gene signature associates with the immune infiltration and predicts the prognosis of glioma patients.

Anoikis-related gene signature associates with the immune infiltration and predicts the prognosis of glioma patients.

Journal: Genes & diseases

Published: January 31, 2024

LincRNA PRNCR1 activates the Wnt/β-catenin pathway to drive the deterioration of hepatocellular carcinoma via regulating miR-411-3p/ZEB1 axis.

LincRNA PRNCR1 activates the Wnt/β-catenin pathway to drive the deterioration of hepatocellular carcinoma via regulating miR-411-3p/ZEB1 axis.

Journal: Biotechnology & genetic engineering reviews

Published: May 27, 2023

HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis.

HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis.

Journal: Journal of gastrointestinal oncology

Published: May 25, 2023

The diversified role of mitochondria in ferroptosis in cancer.

The diversified role of mitochondria in ferroptosis in cancer.

Journal: Cell death & disease

Published: January 05, 2023

PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma.

PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma.

Journal: Translational cancer research

Published: December 11, 2020

CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.

CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.

Journal: Cell death & disease

Published: October 21, 2019

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma.

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma.

Journal: PeerJ

Published: July 12, 2019

WITHDRAWN: Prognostic biomarker AASS suppresses proliferation, migration and predicts a good survival of hepatocellular carcinoma in vivo and in vitro.

WITHDRAWN: Prognostic biomarker AASS suppresses proliferation, migration and predicts a good survival of hepatocellular carcinoma in vivo and in vitro.

Journal: Life sciences

Published: March 29, 2019

Autophagy-deficiency in hepatic progenitor cells leads to the defects of stemness and enhances susceptibility to neoplastic transformation.

Autophagy-deficiency in hepatic progenitor cells leads to the defects of stemness and enhances susceptibility to neoplastic transformation.

Journal: Cancer letters

Published: September 02, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026